Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Other Non-Current Assets (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Other Non-Current Assets for 15 consecutive years, with $549000.0 as the latest value for Q4 2025.

  • Quarterly Other Non-Current Assets rose 695.65% to $549000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $549000.0 through Dec 2025, up 695.65% year-over-year, with the annual reading at $549000.0 for FY2025, 695.65% up from the prior year.
  • Other Non-Current Assets hit $549000.0 in Q4 2025 for Cardiff Oncology, roughly flat from $549000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q2 2023 to a low of $69000.0 in Q4 2024.
  • Historically, Other Non-Current Assets has averaged $694100.0 across 5 years, with a median of $475000.0 in 2025.
  • Biggest five-year swings in Other Non-Current Assets: plummeted 94.61% in 2024 and later surged 695.65% in 2025.
  • Year by year, Other Non-Current Assets stood at $239000.0 in 2021, then surged by 480.33% to $1.4 million in 2022, then fell by 7.79% to $1.3 million in 2023, then tumbled by 94.61% to $69000.0 in 2024, then soared by 695.65% to $549000.0 in 2025.
  • Business Quant data shows Other Non-Current Assets for CRDF at $549000.0 in Q4 2025, $549000.0 in Q3 2025, and $401000.0 in Q2 2025.